← Back to Search

Aerobic vs Resistance Exercise for Type 1 Diabetes

N/A
Recruiting
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with type 1 diabetes for at least one year
Post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from 0 minutes to 45 minutes (during exercise)
Awards & highlights

Study Summary

This trial will test the effects of different types of exercise on blood sugar levels in people with diabetes.

Who is the study for?
This trial is for post-menopausal women with Type 1 Diabetes who can exercise and visit the lab in Edmonton. They should have stable diabetes management, no severe complications like heart disease or neuropathy, not smoke, drink heavily, or be significantly overweight.Check my eligibility
What is being tested?
The study compares how moderate aerobic exercise (like walking), resistance training (like weight-lifting), and no exercise affect blood sugar levels in these women. Blood samples will be taken during and after sessions to monitor glucose changes.See study design
What are the potential side effects?
While there are generally no direct side effects from participating in moderate exercise, individuals may experience low blood sugar episodes or muscle soreness. It's important to follow safety guidelines provided by the researchers.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with type 1 diabetes for over a year.
Select...
I have been in menopause for at least a year or have had my uterus and ovaries removed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from 0 minutes to 45 minutes (beginning to the end of exercise/control) and then for 60 minutes after exercise
This trial's timeline: 3 weeks for screening, Varies for treatment, and from 0 minutes to 45 minutes (beginning to the end of exercise/control) and then for 60 minutes after exercise for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood glucose
Secondary outcome measures
carbohydrate supplementation
coefficient of variation (CV) of CGM glucose
frequency of hyperglycemia
+6 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment3 Interventions
All participants will take part in all three testing conditions

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
898 Previous Clinical Trials
387,463 Total Patients Enrolled
Women and Children's Health Research Institute, CanadaOTHER
17 Previous Clinical Trials
24,920 Total Patients Enrolled

Media Library

Aerobic Exercise Clinical Trial Eligibility Overview. Trial Name: NCT05188027 — N/A
Type 1 Diabetes Research Study Groups: All participants
Type 1 Diabetes Clinical Trial 2023: Aerobic Exercise Highlights & Side Effects. Trial Name: NCT05188027 — N/A
Aerobic Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05188027 — N/A
~7 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top